Patents Assigned to AtheroGenic, Inc.
  • Compounds and methods for the inhibition of the expression of VCAM-1
    Patent number: 7189870
    Abstract: This invention is in the area of methods and compositions for the inhibition of the expression of VCAM-1 and, in particular, for the treatment of diseases mediated by VCAM-1, including cardiovascular and inflammatory diseases.
    Type: Grant
    Filed: August 25, 2003
    Date of Patent: March 13, 2007
    Assignee: AtheroGenic, Inc.
    Inventor: Patricia K. Somers